IP Cases — 2024
4,762 decisions across all jurisdictions
Page 9 of 159 · 4,762 total
Imperative Care, Inc. v.Inari Medical, Inc.
Imperative Care challenges Inari Medical's hemostasis valve patent (11554005) on obviousness grounds. The PTAB instituted the IPR, requiring further review of claims 1-15 based on prior art combinations.
Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.
The PTAB denied Micron's IPR petition against Yangtze Memory because the patent owner had successfully filed a statutory disclaimer covering all challenged claims related to 3D memory devices.
Koki Holdings America Ltd. et al. v.Kyocera Senco Industrial Tools, Inc.
Koki Holdings America Ltd. successfully petitioned to institute IPR proceedings against Kyocera Senco Industrial Tools, Inc., challenging 20 claims of U.S. Patent No. 10478954 on grounds of obviousness (35 U.S.C. § 103). The Board's decision was supported by preliminary claim construction findings that favored the Petitioner’s argument regarding design motivation and prior art combination.
Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.
Micron Technology's IPR petition against Yangtze Memory Technologies was denied by the PTAB. The Board found that Micron failed to demonstrate a reasonable likelihood of prevailing on the merits, specifically regarding obviousness over prior art Costa in 3D memory technology.
Arm Ltd et al. v.DAEDALUS PRIME LLC
Arm Ltd et al. successfully convinced the PTAB to institute an IPR against DAEDALUS PRIME LLC's patent, challenging claims based on obviousness over multiple prior art references. The Board accepted that a reasonable likelihood of prevailing existed on at least one claim challenge, moving the case into the merits phase.
Arm Ltd et al. v.DAEDALUS PRIME LLC
The Director granted review and vacated a denial of institution for Arm Ltd against DAEDALUS PRIME LLC, referring the IPR back to the Board after parallel litigation was dismissed.
Pfizer Inc. v.Everest Pharmaceuticals Limited
The plaintiffs, Pfizer Inc. and its subsidiaries, filed a suit alleging that the defendants unlawfully manufactured, sold, and exported the infringing product 'Tofaxen', which is a generic version of their patented drug Tofacitinib (Xeljanz®). The court found that the defendants collectively infringed the suit patents while they were valid and subsisting. However, since the patents had expired during the pendency of the suit, the plaintiffs did not press for permanent injunction but secured a decree in terms of prayer clause 57(e).
Candico (I) Limited v.T.R. Kohli, Trading As T.R. Kohli And Sons
The Delhi High Court set aside a previous order that had refused the registration of the mark 'JUMBO GUMBO' due to an opposition. The court found that the objection raised by the opponent did not survive because their prior trademark application for 'JUMBO' had been treated as abandoned years earlier. Given the changed circumstances and the opponent's failure to contest the appeal, the High Court directed the Trade Marks Registry to proceed with the registration of 'JUMBO GUMBO'.
Surindar Pal Singh v.Ichhadhari Lassi Old Ichhadhari Lassi and New Ichhadhari and Others
The Madhya Pradesh High Court listed the case involving Surindar Pal Singh and Ichhadhari Lassi Old Ichhadhari Lassi. The court granted time to both parties to verify the outcome or status of a pending rectification application filed under Section 57 of the Trademarks Act. This indicates that the dispute over the trademark's validity or registration is still active and awaiting further judicial determination.
Puma Se v.Surender Singh And Anr.
The Delhi High Court allowed Puma Se's petition seeking cancellation of a deceptively similar trademark, 'P11MA,' registered by Surender Singh in Class 25. The court found that the respondent had slavishly copied the petitioner's established and well-known mark, PUMA, leading to a high likelihood of consumer confusion. Furthermore, the respondent voluntarily agreed not to contest the petition, solidifying the decision for removal.
Spv Laboratories Private Limited v.The Controller General Of Patents And Designs
The appellant filed an appeal challenging the refusal by the Assistant Controller to restore Patent No. 403793, which had lapsed due to non-payment of the renewal fee. The appellant argued that the delay was caused by a family exigency involving its attorney and that the restoration application was filed within the prescribed period. The High Court allowed the appeal, setting aside the impugned order.
Hand Held Products, Inc. v.Scandit AG
This is a procedural order issued by the Local Chamber Hamburg concerning a patent infringement action regarding EP 3 764 271. The plaintiff Hand Held Products, Inc. filed suit on November 6, 2024, alleging infringement by the defendant Scandit AG, which is based in Switzerland. The order resolves a discrepancy between the actual date of service (November 20, 2024) and the date automatically recorded in the Case Management System (November 23, 2024), which was based on an inapplicable service fiction under Rule 271.6 of the Rules of Procedure.
Valeo Electrification v.Respondent
This is a procedural order from the Düsseldorf Local Division concerning European Patent EP 3 320 602 B1, involving an infringement action and counterclaim for revocation. The Claimant (Valeo Electrification) requested an extension of time limits for filing its Reply to the Statement of Defence and Defence to the Counterclaim for Revocation. The Court harmonised the time limits and set the deadline at 14 January 2025, but rejected the request for any further extension beyond the statutory period.
Microsoft Corporation v.Respondent
This order concerns Microsoft Corporation's request for leave to appeal a prior order (ORD_62739/2024) that granted the respondent Suinno Mobile & AI Technologies Licensing Oy leave to reduce its damages claim to €2 million in an infringement action concerning European patent EP 2 671 173. Microsoft argued that leave to appeal would clarify the scope and limits of the Court's powers in interpreting a party's request under Article 76(1) UPCA and the admissible scope of an application under Rule 263 RoP. The Court addressed the legal framework for granting leave to appeal, noting it is an exception to the general principle that interlocutory orders may only be reviewed together with the appeal against the final decision.
Syngenta Limited v.Sumi Agro Limited, Sumi Agro Europe Limited
Syngenta Limited sought to revoke a preliminary measures order (ORD 47657/2024) against Sumi Agro Limited and Sumi Agro Europe Limited, arguing that the underlying main proceedings on the merits were not timely started within the non-extendable deadlines under Rule 213.1 RoP. The Local Division Munich dismissed the application, holding that the proceedings were validly started when the Statement of Claim was uploaded to the CMS on 27 September 2024, and that Rule 15(2) RoP does not require court fees to have been physically received by the Court before the deadline expires.
Intel Corporation et al. v.Collision Communications, Inc.
Intel, Lenovo, and Motorola filed a motion to dismiss their IPR against Collision Communications. The PTAB granted the motion, dismissing the petition and terminating the proceeding.
Lenovo (United States) Inc. et al. v.Collision Communications, Inc.
Lenovo and Motorola filed a motion to dismiss their IPR against Collision Communications, arguing good cause to withdraw before institution, citing prior PTAB precedent and a denied related Samsung IPR.
Entegris, Inc. v.Inpria Corporation
Entegris contests Inpria’s request for Director Review of the PTAB’s institution of an IPR, arguing that Lam Research is not a real party in interest and that Inpria’s claim‑construction arguments are untimely.
Entegris, Inc. v.Inpria Corporation
Entegris seeks rehearing of the USPTO’s denial to institute an IPR against Inpria’s ’903 patent covering semiconductor‑material compounds. The petition argues the Director’s retroactive rescission of guidance and misapplication of Fintiv factors violated statutory and due‑process requirements.
Entegris, Inc. v.Inpria Corporation
Inpria seeks director review to vacate the PTAB’s institution of an IPR against its ’903 patent, arguing Entegris failed the real‑party‑in‑interest test and that the Board’s claim construction conflicts with a Delaware court ruling.
Entegris, Inc. v.Inpria Corporation
The USPTO granted Entegris’s rehearing request, vacated the earlier discretionary denial, and sent the IPR on Inpria’s lithography patent back to the Board for institution after a related district‑court case settled.
Entegris, Inc. v.Inpria Corporation
Entegris and Inpria have settled their dispute over U.S. Patent No. 11,673,903 and jointly moved to terminate the inter partes review. The Board had previously instituted the proceeding but no merits were decided.
Entegris, Inc. v.Inpria Corporation
Entegris filed a motion to seal its confidential response to Inpria’s request for director review in IPR2025-00267, citing the need to protect trade‑secret information.
Entegris, Inc. v.Inpria Corporation
The PTAB instituted inter partes review of Entegris' challenge to Inpria's 11,673,903 patent covering high‑purity organotin compounds, finding a reasonable likelihood of unpatentability.
Entegris, Inc. v.Inpria Corporation
Entegris and Inpria filed a joint request to keep their settlement agreement confidential under 35 U.S.C. § 317(b) and related regulations, arguing that disclosure would harm their business interests.
X Corp. v.Sterling Computers Corporation
X Corp. petitions the PTAB to invalidate Sterling Computers’ 7,716,217 patent covering email relevance scoring, asserting that all 22 claims are obvious over prior art such as Dumais, Kircher, Krug, and Marston. The petition also argues that discretionary denial is unwarranted.
Entegris, Inc. v.Inpria Corporation
Entegris has filed an IPR petition seeking cancellation of claims 1‑4 and 6‑10 of Inpria’s ’903 patent, asserting that the claimed high‑purity organotin compositions are fully disclosed in earlier literature. The petition challenges the patent on anticipation and obviousness grounds and argues that Inpria’s examiner‑era declarations were misleading.
X Corp. v.Sterling Computers Corporation
X Corp.'s IPR petition against Sterling Computers Corporation's patent (7716217) was instituted, finding a reasonable likelihood of prevailing on obviousness grounds. The Board found that combining Kircher and Krug would motivate a POSITA to improve relevance scoring in email content ranking.
Intel Corporation et al. v.Collision Communications, Inc.
The PTAB denied institution of an IPR filed by Intel and others against Collision Communications regarding wireless multiuser detection claims. The denial was based on the Fintiv factors, noting that the parallel district court trial date was too close to the Board's statutory deadline.
Lenovo (United States) Inc. et al. v.Collision Communications, Inc.
The PTAB denied Lenovo and Motorola's request to institute IPR against Collision Communications regarding patent 6947505. The denial was based on the Petitioner failing to show a reasonable likelihood of success, mirroring a prior adverse ruling in related proceedings.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.